Aviwell SAS, a Toulouse-based deep-tech animal nutrition company with operations spanning France and Boston, has closed a €11 million Series A financing to expand its AI-driven microbiome discovery and development platform and advance nature-based biological solutions for global agri-food markets, initially focused on poultry and aquaculture. The round brings in three new investors: Blue Revolution Fund (BRF), Blast.Club, and SWEN Capital Partners. Existing investors Elaia and MFS Investment Management also participated, according to the company.
Aviwell’s core technology centers on Aneto, an AI-powered microbiome discovery platform designed to identify specific molecular mechanisms—modes of action—that inform the selection of native bacterial communities. The company says this enables the creation of tailored bacterial ecologies to improve animal performance, support immunity, and increase robustness. Aviwell positions the approach as a faster and more cost-efficient discovery process that can reduce R&D timelines and accelerate commercialization.
The company said the new capital will be used to move its poultry and aquaculture microbial ecologies from discovery into validation and scale-up, while also expanding Aneto platform services, strengthening discovery and demonstration capabilities, and deepening commercial engagement with partners and customers.
Aviwell is seeking to capitalize on what it describes as converging market forces, including rising global demand for animal protein and shifting consumer preferences toward natural, sustainable, antibiotic-free production systems. The company’s strategy is to translate microbiome science into scalable solutions intended to improve productivity while reducing reliance on antibiotics and lowering environmental impact.
KEY QUOTES
“Aviwell sits at the intersection of two powerful market forces: rising global demand for animal protein, and the accelerating consumer shift toward natural, sustainable, antibiotic-free production systems. With Aneto, we can translate microbiome complexity into practical, scalable solutions, helping livestock and aquaculture producers improve productivity while reducing their environmental footprint. With the support of our new investors, Aviwell will accelerate development in poultry and aquaculture and expand our platform and product pipeline.”
Mouli Ramani, President and CEO, Aviwell
“We are deeply impressed by Aviwell’s scientific depth and technological precision. Aneto represents a new generation of microbiome innovation-one that captures the inherent complexity of biological systems. We believe this approach can unlock the next wave of solutions for poultry, aquaculture and livestock in general by delivering meaningful improvements in performance, resilience and environmental footprint.”
Georg Baunach, Managing Partner, Blue Revolution Fund (BRF)
“We invested in Aviwell for one simple reason: they are revolutionizing the agri-food industry. Aviwell uses AI and life sciences to naturally boost animal growth, without hormones or antibiotics, simply by working on the microbiota. That’s what we like: impact, innovation and a real long-term vision. Feeding better, in a healthier, more sustainable way. Changing the rules of the game instead of playing by them.”
Anthony Bourbon, Founder, Blast.Club
“Investing in the microbiome means investing in the future of health and a sustainable economy. For us, supporting Aviwell is about building a measurable, sustainable economic model – reducing chronic disease costs and creating responsible, long-term value.”
Julien Bourret, Investment Director, SWEN Capital Partners
